Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is 6.78% vs 18.01% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 64.33% vs -15.49% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is 95.28% vs -19.65% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is -3.08% vs -4.41% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Astrazeneca Phar With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 6.78% vs 18.01% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 30.41% vs 37.03% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is 64.33% vs -15.49% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 14.96% vs 41.09% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 95.28% vs -19.65% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 27.12% vs 43.09% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is -3.08% vs -4.41% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 182.09% vs 97.06% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025